Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solaris Disinfection is a healthcare technology company specializing in automated UV-C disinfection solutions designed to eliminate pathogens in clinical environments. Their flagship product, the Lytbot, utilizes pulsed xenon UV light to provide rapid and effective disinfection of high-touch surfaces and air, helping hospitals reduce healthcare-associated infections (HAIs). The company focuses on providing portable, easy-to-use, and data-driven disinfection systems that integrate into existing hospital workflows. By targeting a broad spectrum of microorganisms, including multi-drug resistant organisms, Solaris aims to enhance patient safety and environmental hygiene.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solaris Disinfection.